BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thomson DM, Mitchell EJ, Openshaw RL, Pratt JA, Morris BJ. Mice lacking melatonin MT2 receptors exhibit attentional deficits, anxiety and enhanced social interaction. J Psychopharmacol 2021;:2698811211032439. [PMID: 34304635 DOI: 10.1177/02698811211032439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Millan MJ. Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action. Ther Adv Psychopharmacol 2022;12:20451253221105128. [PMID: 35795687 DOI: 10.1177/20451253221105128] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Boiko DI, Shkodina AD, Hasan MM, Bardhan M, Kazmi SK, Chopra H, Bhutra P, Baig AA, Skrypnikov AM. Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression. Neurochem Res 2022. [PMID: 35689787 DOI: 10.1007/s11064-022-03646-5] [Reference Citation Analysis]
3 Wang YQ, Jiang YJ, Zou MS, Liu J, Zhao HQ, Wang YH. Antidepressant actions of melatonin and melatonin receptor agonist: Focus on pathophysiology and treatment. Behav Brain Res 2021;420:113724. [PMID: 34929236 DOI: 10.1016/j.bbr.2021.113724] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]